ICD-10/NCCI diagnosis coding edits and claim denial guidance
Customize your policy alerts
Sign up for all memorialcareselecthealthplan policy alerts
Know when memorialcareselecthealthplan releases new policies or updates existing guidance.
Monitor payer policy activity
Governs diagnosis coding requirements aligned with CMS NCCI and ICD-10 standards for participating providers submitting claims to MemorialCare Select Health Plan; includes guidance on causes for denials and remediation steps. Affects physicians, participating physician groups, hospitals, and ancillary providers (with county-specific note for Medi-Cal).
No material clinical or coverage changes in this revision.
Diagnosis Coding and Claim Submission Criteria
Diagnosis coding requirement criteria
Coding and claim submission requirements and edits that may result in denials if not followed:
Denial codes that may appear on the remittance advice
- EXwd: diagnosis code incorrectly coded per ICD‑10 Manual.
- Denial code 255 (coding edit).
Chemotherapy/immunotherapy diagnosis requirement
- When a chemotherapy CPT code is present on a professional or facility claim, Z51.11 (Encounter for antineoplastic chemotherapy) or Z51.12 (Encounter for antineoplastic immunotherapy) must be the Primary/First‑Listed/Principal diagnosis unless the therapy is for a non‑neoplastic condition or the Primary diagnosis is Z51.0 (Encounter for antineoplastic radiation therapy).
- If the required primary diagnosis for chemotherapy/immunotherapy is missing, the claim line will be edited and may be denied.
Denial Codes and Specific Diagnosis Rules
| EXwd | Denial code: diagnosis code incorrectly coded per ICD-10 Manual. |
| 255 | Denial code referenced for coding edits. |
| Z51.11 | Encounter for antineoplastic chemotherapy — must be Primary/First‑Listed/Principal diagnosis when a chemotherapy CPT code is present unless therapy is for a non‑neoplastic condition or primary diagnosis is Z51.0. |
| Z51.12 | Encounter for antineoplastic immunotherapy — must be Primary/First‑Listed/Principal diagnosis when an immunotherapy CPT code is present unless therapy is for a non‑neoplastic condition or primary diagnosis is Z51.0. |
Claims Correction, Appeals, and Compliance Actions
Claim corrections and appeals — follow provider operations manuals
Providers may submit the corrected claim or submit an appeal or reconsideration request as outlined in the provider operations manuals. The provider operations manuals are available in the Provider Library after logging into the Health Net provider portal (http://providerlibrary.healthnetcalifornia.com).
- Submit corrected claims following the process in the provider operations manuals.
- Submit appeals or reconsideration requests per the provider operations manuals.
- Access the Provider Library by logging into the Health Net provider portal to find the manuals.
NCCI compliance required — Health Net will review coding edits
Participating providers must adhere to CMS National Correct Coding Initiative (NCCI) standards; Health Net will begin reviewing claims for correct coding edits to align with NCCI and ICD-10, and noncompliance may result in claim denials.
- Use NCCI standards and ICD-10 guidance when assigning diagnosis codes.
- Refer to the ICD-10 Manual for code sources and details before resubmitting denied claims.
- Beginning March 1, 2021, Health Net will review claims for these correct coding edits.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.